Camille Lobry

5.4k total citations
25 papers, 1.8k citations indexed

About

Camille Lobry is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Camille Lobry has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Hematology and 7 papers in Immunology. Recurrent topics in Camille Lobry's work include Acute Myeloid Leukemia Research (9 papers), Epigenetics and DNA Methylation (5 papers) and Immune Cell Function and Interaction (4 papers). Camille Lobry is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Epigenetics and DNA Methylation (5 papers) and Immune Cell Function and Interaction (4 papers). Camille Lobry collaborates with scholars based in United States, France and Belgium. Camille Lobry's co-authors include Iannis Aifantis, Philmo Oh, Marc R. Mansour, A. Thomas Look, Omar Abdel‐Wahab, Ross L. Levine, Thomas Trimarchi, Robert Weil, Cynthia Liu and Elisa Araldi and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Camille Lobry

24 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Camille Lobry 1.1k 504 374 357 320 25 1.8k
Yutaka Okuno 1.2k 1.0× 511 1.0× 391 1.0× 694 1.9× 278 0.9× 66 1.9k
Wolf-Karsten Hofmann 1.1k 0.9× 493 1.0× 372 1.0× 634 1.8× 186 0.6× 11 1.7k
Alan G. Rosmarin 985 0.9× 414 0.8× 332 0.9× 262 0.7× 195 0.6× 47 1.7k
Hong Sai 1.3k 1.1× 489 1.0× 345 0.9× 337 0.9× 178 0.6× 12 1.9k
Sebastian Herzog 713 0.6× 485 1.0× 241 0.6× 296 0.8× 226 0.7× 43 1.4k
Jana Krošl 1.3k 1.2× 430 0.9× 435 1.2× 777 2.2× 190 0.6× 38 2.1k
Cornelia Rudolph 1.4k 1.2× 287 0.6× 523 1.4× 208 0.6× 227 0.7× 41 2.1k
Lauren D. Wood 1.2k 1.1× 196 0.4× 580 1.6× 240 0.7× 335 1.0× 20 1.7k
Silvia Monestiroli 1.3k 1.1× 292 0.6× 726 1.9× 314 0.9× 402 1.3× 13 1.8k
Lin Tai 1.1k 0.9× 418 0.8× 428 1.1× 108 0.3× 174 0.5× 27 1.4k

Countries citing papers authored by Camille Lobry

Since Specialization
Citations

This map shows the geographic impact of Camille Lobry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille Lobry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille Lobry more than expected).

Fields of papers citing papers by Camille Lobry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille Lobry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille Lobry. The network helps show where Camille Lobry may publish in the future.

Co-authorship network of co-authors of Camille Lobry

This figure shows the co-authorship network connecting the top 25 collaborators of Camille Lobry. A scholar is included among the top collaborators of Camille Lobry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille Lobry. Camille Lobry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vianay, Benoît, Stéphanie Mathis, Sofiane Fodil, et al.. (2025). AML patient blasts exhibit polarization defects upon interaction with bone marrow stromal cells. EMBO Reports. 26(13). 3264–3279.
2.
Ganesan, Saravanan, Fabien Guidez, Nabih Maslah, et al.. (2024). Comprehensive analysis of mesenchymal cells reveals a dysregulated TGF-β/WNT/HOXB7 axis in patients with myelofibrosis. JCI Insight. 9(23). 1 indexed citations
3.
Benbarche, Salima, Cécile K. Lopez, Eralda Salataj, et al.. (2022). Screening of ETO2-GLIS2–induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia. Science Advances. 8(6). eabg9455–eabg9455. 9 indexed citations
4.
Diop, M’Boyba, Julie Rivière, Gérard Pierron, et al.. (2019). Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages. Nature Communications. 10(1). 1935–1935. 24 indexed citations
5.
Lobry, Camille, et al.. (2019). Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH). Experimental Hematology and Oncology. 8(1). 17–17. 2 indexed citations
6.
Proudhon, Charlotte, Valentina Snetkova, Ramya Raviram, et al.. (2016). Active and Inactive Enhancers Cooperate to Exert Localized and Long-Range Control of Gene Regulation. Cell Reports. 15(10). 2159–2169. 27 indexed citations
7.
Cimmino, Luisa, Meelad M. Dawlaty, Delphine Ndiaye‐Lobry, et al.. (2015). TET1 is a tumor suppressor of hematopoietic malignancy. Nature Immunology. 16(6). 653–662. 170 indexed citations
8.
Kim, Eun Hee, Janine O. Ilagan, Stanley Chun-Wei Lee, et al.. (2014). SRSF2 Mutations Impair Hematopoietic Differentiation By Altering Exonic Splicing Enhancer Preference. Blood. 124(21). 824–824. 2 indexed citations
9.
Gough, Daniel J., Isabelle Marié, Camille Lobry, Iannis Aifantis, & David T. Levy. (2014). STAT3 supports experimental K-RasG12D–induced murine myeloproliferative neoplasms dependent on serine phosphorylation. Blood. 124(14). 2252–2261. 50 indexed citations
10.
Lobry, Camille, Philmo Oh, Marc R. Mansour, A. Thomas Look, & Iannis Aifantis. (2014). Notch signaling: switching an oncogene to a tumor suppressor. Blood. 123(16). 2451–2459. 193 indexed citations
11.
Oh, Philmo, Camille Lobry, Jie Gao, et al.. (2013). In Vivo Mapping of Notch Pathway Activity in Normal and Stress Hematopoiesis. Cell stem cell. 13(2). 190–204. 69 indexed citations
12.
Guy, Clifford S., Kate M. Vignali, Jamshid Temirov, et al.. (2013). Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nature Immunology. 14(3). 262–270. 181 indexed citations
13.
Araten, David J., et al.. (2012). A Role for TET2 Mutations in Paroxysmal Nocturnal Hemoglobinuria (PNH). Blood. 120(21). 1262–1262. 1 indexed citations
14.
Klinakis, Apostolos, Camille Lobry, Omar Abdel‐Wahab, et al.. (2011). A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature. 473(7346). 230–233. 271 indexed citations
15.
Lobry, Camille, Philmo Oh, & Iannis Aifantis. (2011). Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think. The Journal of Experimental Medicine. 208(10). 1931–1935. 275 indexed citations
16.
Germar, Kristine, Marei Dose, Jiangwen Zhang, et al.. (2011). T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proceedings of the National Academy of Sciences. 108(50). 20060–20065. 164 indexed citations
17.
Vlierberghe, Pieter Van, Jay Patel, Omar Abdel‐Wahab, et al.. (2010). PHF6 mutations in adult acute myeloid leukemia. Leukemia. 25(1). 130–134. 124 indexed citations
18.
Lobry, Camille & Robert Weil. (2007). Mécanismes régulateurs de la voie NF-κB dans les lymphocytes T. médecine/sciences. 23(10). 857–861. 3 indexed citations
19.
Lobry, Camille & Robert Weil. (2007). Nouveaux mécanismes régulateurs de Bcl10 : une avancée dans la compréhension de la survenue des lymphomes du MALT  ?. médecine/sciences. 23(4). 353–355. 6 indexed citations
20.
Lobry, Camille, Tatiana López, Alain Israël, & Robert Weil. (2007). Negative feedback loop in T cell activation through IκB kinase-induced phosphorylation and degradation of Bcl10. Proceedings of the National Academy of Sciences. 104(3). 908–913. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026